Moreover, compared to other malignant tumors, such as melanoma [68] and Hodgkin’s lymphoma [69], the efficacy of anti-PD-1/PD-L1 monotherapy in treatment of advanced ICC remains limited [70]. This evidence concerns the gene CD274 and Hodgkins lymphoma.